5.76
price up icon6.70%   0.24
after-market After Hours: 5.81 0.05 +0.87%
loading
Lyra Therapeutics Inc stock is traded at $5.76, with a volume of 13,640. It is up +6.70% in the last 24 hours and down -9.75% over the past month. Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
See More
Previous Close:
$5.52
Open:
$5.53
24h Volume:
13,640
Relative Volume:
0.51
Market Cap:
$9.47M
Revenue:
$770.00K
Net Income/Loss:
$-38.84M
P/E Ratio:
-0.4055
EPS:
-14.2049
Net Cash Flow:
$-43.02M
1W Performance:
-7.53%
1M Performance:
-9.75%
6M Performance:
-0.84%
1Y Performance:
-57.15%
1-Day Range:
Value
$5.53
$5.85
1-Week Range:
Value
$5.52
$6.43
52-Week Range:
Value
$3.8101
$37.50

Lyra Therapeutics Inc Stock (LYRA) Company Profile

Name
Name
Lyra Therapeutics Inc
Name
Phone
617-373-4600
Name
Address
480 ARSENAL WAY, WATERTOWN, MA
Name
Employee
30
Name
Twitter
@LyraTx
Name
Next Earnings Date
2025-03-12
Name
Latest SEC Filings
Name
LYRA's Discussions on Twitter

Compare LYRA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
LYRA
Lyra Therapeutics Inc
5.76 9.08M 770.00K -38.84M -43.02M -14.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 398.11M -1.03B -868.57M -5.7032

Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades

Date Action Analyst Rating Change
May-07-24 Downgrade BofA Securities Buy → Underperform
May-07-24 Downgrade H.C. Wainwright Buy → Neutral
May-07-24 Downgrade Jefferies Buy → Hold
May-06-24 Downgrade William Blair Outperform → Mkt Perform
Oct-06-23 Resumed BTIG Research Buy
Aug-31-23 Initiated H.C. Wainwright Buy
May-24-22 Initiated Cantor Fitzgerald Overweight
May-26-20 Initiated BTIG Research Buy
May-26-20 Initiated BofA/Merrill Buy
May-26-20 Initiated Jefferies Buy
May-26-20 Initiated William Blair Outperform
View All

Lyra Therapeutics Inc Stock (LYRA) Latest News

pulisher
06:43 AM

Will Lyra Therapeutics Inc. stock see insider buyingTrade Signal Summary & Expert Approved Momentum Trade Ideas - newser.com

06:43 AM
pulisher
06:01 AM

Risk adjusted return profile for Lyra Therapeutics Inc. analyzedWeekly Market Outlook & High Accuracy Buy Signal Tips - newser.com

06:01 AM
pulisher
05:34 AM

Is Lyra Therapeutics Inc. stock attractive for long term wealth buildingPortfolio Gains Summary & AI Optimized Trading Strategy Guides - newser.com

05:34 AM
pulisher
05:08 AM

How Lyra Therapeutics Inc. stock benefits from global expansionJuly 2025 Review & Low Drawdown Trading Strategies - newser.com

05:08 AM
pulisher
04:31 AM

Is Lyra Therapeutics Inc. meeting your algorithmic filter criteriaWeekly Stock Summary & Daily Technical Stock Forecast Reports - newser.com

04:31 AM
pulisher
02:21 AM

Identifying reversal signals in Lyra Therapeutics Inc.July 2025 Retail & Advanced Technical Signal Analysis - newser.com

02:21 AM
pulisher
12:59 PM

What indicators show strength in Lyra Therapeutics Inc.Weekly Stock Summary & Technical Buy Zone Confirmations - newser.com

12:59 PM
pulisher
12:53 PM

Is Lyra Therapeutics Inc. still worth holding after the dipRate Hike & Low Drawdown Investment Strategies - newser.com

12:53 PM
pulisher
Oct 30, 2025

Why Lyra Therapeutics Inc. stock could see breakout soonGlobal Markets & Expert Curated Trade Setup Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Will Lyra Therapeutics Inc. outperform the market2025 Year in Review & Proven Capital Preservation Tips - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Can a trend reversal in Lyra Therapeutics Inc. lead to recoveryJuly 2025 WrapUp & AI Enhanced Trading Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Price momentum metrics for Lyra Therapeutics Inc. explainedJuly 2025 Closing Moves & Stepwise Trade Execution Plans - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Is Lyra Therapeutics Inc. stock a bargain at current levelsFed Meeting & Daily Risk Controlled Trade Plans - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Published on: 2025-10-29 21:52:23 - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

What valuation multiples suggest for Lyra Therapeutics Inc. stockInsider Selling & Technical Entry and Exit Tips - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Will earnings trigger a reversal in Lyra Therapeutics Inc.2025 Fundamental Recap & Daily Volume Surge Trade Alerts - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Order flow analysis tools used on Lyra Therapeutics Inc.Portfolio Value Report & Risk Adjusted Swing Trade Ideas - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How Lyra Therapeutics Inc. stock responds to policy changesPortfolio Performance Summary & Daily Stock Trend Watchlist - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Aug Selloffs: Is Lyra Therapeutics Inc. stock a bargain at current levelsJuly 2025 Volume & AI Driven Stock Price Forecasts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

How buybacks impact Lyra Therapeutics Inc. stock valuePortfolio Value Report & Risk Adjusted Buy and Sell Alerts - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Published on: 2025-10-27 05:33:04 - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Lyra Therapeutics Stock Fell 11% in a Week, What Now? - Trefis

Oct 27, 2025

Lyra Therapeutics Inc Stock (LYRA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Lyra Therapeutics Inc Stock (LYRA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Palasis Maria
President & CEO
Jul 10 '25
Sale
8.91
1,565
13,944
1,098,435
Cavalier Jason
Chief Financial Officer
Jul 10 '25
Sale
8.91
684
6,094
519,316
$37.54
price up icon 1.68%
$93.48
price up icon 0.95%
$28.61
price down icon 0.23%
$103.91
price down icon 0.72%
biotechnology ONC
$310.48
price up icon 0.71%
$189.60
price down icon 2.34%
Cap:     |  Volume (24h):